100 of the hottest medtech startups of 2020 will share their plans for growth and investment/partnering needs to a full house of investors and strategics.
LAGUNA NIGUEL, Calif.–(BUSINESS WIRE)–#lsintelligence—Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators.
In addition to startup CEO presentations, the event will include panel discussions on timely industry topics with venture capitalists, large corporates, and industry thought leaders.
Registration will close on February 15th or sooner and attendance is limited. Registration and full program details are here.
Investors attending: JJDC, Sante Ventures, Connecticut Innovations, US Venture Partners, NEA, Pangaea Ventures, SV Health Investors, Miraki Innovation Fund, MVM Partners, Evonik VC, Sands Capital, Mayo Clinic Ventures, HealthTech Capital, Grey Sky Venture Partners, and more.
Strategics attending: J&J, Medtronic, Boston Scientific, Edwards Lifesciences, Terumo, Fresenius, Intuitive Surgical, BD, W.L. Gore, and more.
Startup presenting companies:
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.
Contacts
Maricela Almonte
Life Science Intelligence
714 847 3540 Tel
maricela@LS-intel.com
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH),…
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH),…
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH),…
New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…
Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…